Stocklytics Platform
Asset logo for symbol ALDX
Aldeyra Therapeutics
ALDX52
$2.18arrow_drop_down2.66%-$0.06
Asset logo for symbol ALDX
ALDX52

$2.18

arrow_drop_down2.66%

Income Statement (ALDX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$14.63M-$16.36M-$7.58M-$4.23M-$7.64M
EBITDA-$14.57M-$16.30M-$7.52M-$4.17M-$7.58M
gross Profit--$61.63K-$60.63K$326.15K-$64.99K
NET Income-$15.11M-$16.84M-$8.08M-$4.75M-$8.18M
total Revenue$0.00$0.00$0.00$392.62K$0.00

Balance Sheet (ALDX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt-$12.50M-$15.39M-$36.83M-$127.16M-$127.15M
stockholders Equity$85.09M$98.31M$113.41M$119.79M$123.00M
total Assets$117.31M$126.04M$141.30M$148.32M$147.28M
total Debt$15.61M$15.63M$15.65M$15.65M$16.18M
total Liabilities$32.22M$27.73M$27.88M$28.53M$24.27M

Cash Flow (ALDX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow-$197.39K$0.00$18.19K-$1.01M-$315.75K
free Cash Flow-$7.97M-$13.22M-$9.97M$500.44K-$8.02M
investing Cash Flow-----
operating Cash Flow-$7.97M-$13.22M-$9.97M$500.44K-$8.02M

Aldeyra Therapeutics (ALDX) Financials

Aldeyra Therapeutics Inc (ALDX) is a biotechnology company that focuses on the development and commercialization of innovative therapies for immune-mediated diseases. The company's income statement shows its financial performance over a specific period. The income statement includes revenue, expenses, and net income. ALDX's total revenue represents the amount of money earned from its operations. The gross profit is the difference between total revenue and the cost of goods sold, representing the company's profitability. The net income from stockholders is the profit left after deducting taxes and interest expenses. It shows how much of the company's profits belong to the stockholders.
ALDX's balance sheet provides a snapshot of the company's financial position at a specific point in time. It includes assets, liabilities, and stockholders' equity. Total assets represent the company's resources, such as cash, investments, and property. Total liabilities represent the company's debts and obligations. Stockholders' equity represents the portion of the company's assets that belong to the stockholders. ALDX's cash equivalents refer to highly liquid investments that can be easily converted into cash. Net debt is the difference between a company's total debt and its cash equivalents. It shows the company's ability to meet its financial obligations.
ALDX's cash flow statement shows the cash generated or used by the company during a specific period. It includes operating, investing, and financing activities. Operating cash flow represents the cash generated from the company's normal business operations. Investing cash flow represents the cash used for acquiring or disposing of long-term assets. Financing cash flow represents the cash received or spent on financing activities, such as issuing or repurchasing stock and paying dividends. Free cash flow is the cash left after deducting capital expenditures from operating cash flow. It indicates the company's ability to generate excess cash for various purposes.
Overall, Aldeyra Therapeutics Inc (ALDX) financials provide insights into the company's financial performance, position, and cash flows. These financial statements help investors and analysts evaluate the company's profitability, liquidity, and solvency. By reviewing these financials, stakeholders can make informed decisions regarding their investments in ALDX.
add Aldeyra Therapeutics  to watchlist

Keep an eye on Aldeyra Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level